Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis

Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast cancer has become a model for molecularly guided ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Grewal, Jai, Kesari, Santosh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397517/
https://www.ncbi.nlm.nih.gov/pubmed/18373884
http://dx.doi.org/10.1186/bcr1868
_version_ 1782155633899864064
author Grewal, Jai
Kesari, Santosh
author_facet Grewal, Jai
Kesari, Santosh
author_sort Grewal, Jai
collection PubMed
description Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast cancer has become a model for molecularly guided therapy in solid tumors. Emerging data support that these receptors are associated with risk for developing brain metastases. Additionally, once brain metastases have occurred these receptors may also correlate with prognosis.
format Text
id pubmed-2397517
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23975172008-05-30 Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis Grewal, Jai Kesari, Santosh Breast Cancer Res Editorial Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast cancer has become a model for molecularly guided therapy in solid tumors. Emerging data support that these receptors are associated with risk for developing brain metastases. Additionally, once brain metastases have occurred these receptors may also correlate with prognosis. BioMed Central 2008 2008-03-14 /pmc/articles/PMC2397517/ /pubmed/18373884 http://dx.doi.org/10.1186/bcr1868 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Editorial
Grewal, Jai
Kesari, Santosh
Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title_full Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title_fullStr Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title_full_unstemmed Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title_short Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
title_sort breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397517/
https://www.ncbi.nlm.nih.gov/pubmed/18373884
http://dx.doi.org/10.1186/bcr1868
work_keys_str_mv AT grewaljai breastcancersurfacereceptorspredictriskfordevelopingbrainmetastasisandsubsequentprognosis
AT kesarisantosh breastcancersurfacereceptorspredictriskfordevelopingbrainmetastasisandsubsequentprognosis

Ejemplares similares